Introduction
Herbal medicine, also known as botanical medicine or phytotherapy, uses plants and plant extracts for therapeutic purposes. It is the oldest form of healthcare known to humanity and remains the primary healthcare system for 70-80% of the world’s population. Modern herbal medicine integrates traditional knowledge with scientific investigation of plant pharmacology, efficacy, and safety.
Phytochemistry: Active Constituents
Major Classes of Bioactive Compounds
| Compound Class | Examples | Plant Sources | Pharmacological Activity |
|---|---|---|---|
| Alkaloids | Berberine, caffeine, morphine, quinine | Goldenseal, coffee, poppy, cinchona | Antimicrobial, stimulant, analgesic, antimalarial |
| Flavonoids | Quercetin, catechins, rutin | Onions, green tea, citrus, buckwheat | Antioxidant, anti-inflammatory, vasoprotective |
| Terpenes/Terpenoids | Menthol, thymol, camphor, ginkgolides | Peppermint, thyme, camphor, ginkgo | Expectorant, antimicrobial, cognitive enhancement |
| Phenolic acids | Salicin, rosmarinic acid, ellagic acid | Willow, rosemary, raspberries | Analgesic, anti-inflammatory, antioxidant |
| Saponins | Ginsenosides, glycyrrhizin | Ginseng, licorice | Adaptogenic, anti-inflammatory, immune modulation |
| Glycosides | Cardiac glycosides (digoxin), anthraquinones | Foxglove, senna | Cardiotonic, laxative |
| Tannins | Tannic acid, proanthocyanidins | Witch hazel, cranberry, green tea | Astringent, antimicrobial, antioxidant |
| Coumarins | Warfarin (synthetic), aesculin | Sweet clover, horse chestnut | Anticoagulant, vasoprotective |
| Essential oils | Eucalyptol, linalool, limonene | Eucalyptus, lavender, citrus | Antimicrobial, sedative, anti-inflammatory |
| Polysaccharides | Beta-glucans, inulin | Mushrooms, echinacea, chicory | Immune modulation, prebiotic |
Preparation Methods
Herbal Preparations
| Preparation | Method | Solvent | Ratio (herb:solvent) | Typical Dose | Potency |
|---|---|---|---|---|---|
| Tea/Infusion | Steep herb in hot water | Water | 1 tbsp per cup | 3-4 cups/day | Mild |
| Decoction | Boil tough plant parts (roots, bark) | Water | 1 tbsp per cup | 3-4 cups/day | Moderate |
| Tincture | Soak herb in alcohol/water mix | Ethanol/water | 1:5 to 1:2 | 2-5 mL TID | Strong |
| Fluid extract | Concentrated tincture | Ethanol/water | 1:1 | 1-2 mL TID | Very strong |
| Solid extract | Evaporated to dry/paste | Various | 4:1 to 10:1 | Varies | Highly concentrated |
| Capsule/tablet | Dried herb or extract | N/A | Varies | Per label | Variable |
| Ointment/salve | Herb infused into oil/wax base | Oil/wax | Variable | Topical | Topical |
| Poultice | Fresh herb applied directly | N/A | N/A | Fresh plant | Local |
| Glycerite | Glycerin-based (alcohol-free) | Glycerin | 1:4 to 1:2 | 3-5 mL TID | Moderate |
Major Medicinal Herbs
Evidence Profiles
| Herb (Latin) | Part Used | Key Constituents | Primary Indications | Quality of Evidence | Typical Dose |
|---|---|---|---|---|---|
| Echinacea (E. purpurea) | Aerial, root | Alkamides, polysaccharides, cichoric acid | Prevention and treatment of upper respiratory infections | Moderate (prevention), good (treatment with early use) | 1-3 g dried root TID, 2-5 mL tincture TID |
| St. John’s Wort (Hypericum perforatum) | Aerial | Hypericin, hyperforin, flavonoids | Mild to moderate depression | Strong (multiple meta-analyses) | 300 mg (0.3% hypericin) TID |
| Ginkgo (Ginkgo biloba) | Leaf | Ginkgolides, flavonoids, terpene lactones | Cognitive decline, dementia, peripheral vascular disease | Moderate (dementia), mixed (memory in healthy) | 120-240 mg/day standardized extract |
| Saw Palmetto (Serenoa repens) | Fruit | Fatty acids, phytosterols, flavonoids | Benign prostatic hyperplasia (BPH) | Strong for symptom improvement (not prostate size) | 320 mg/day (standardized extract) |
| Valerian (Valeriana officinalis) | Root | Valerenic acid, valepotriates, volatile oils | Insomnia, anxiety | Moderate (sleep quality, not sleep onset) | 300-600 mg extract 30-60 min before bed |
| Milk Thistle (Silybum marianum) | Seed | Silymarin (silibinin, silydianin, silychristin) | Liver disease (viral hepatitis, NAFLD, toxin exposure) | Moderate (ALT reduction, alcoholic liver disease) | 200-400 mg silymarin/day |
| Ginger (Zingiber officinale) | Rhizome | Gingerols, shogaols, zingerone | Nausea (pregnancy, motion sickness, post-op, chemo) | Strong for nausea | 1-3 g fresh/dried root/day, 250-500 mg extract TID |
| Turmeric (Curcuma longa) | Rhizome | Curcuminoids (curcumin, demethoxycurcumin) | Inflammation, osteoarthritis, metabolic syndrome | Moderate (osteoarthritis), mixed (anti-inflammatory) | 500-2000 mg curcumin with piperine/day |
| Garlic (Allium sativum) | Bulb | Allicin, alliin, ajoene, diallyl sulfides | Cardiovascular health, hypertension, hyperlipidemia, immune | Moderate (mild BP reduction, lipid lowering) | 600-1200 mg aged extract/day |
| Feverfew (Tanacetum parthenium) | Leaf | Parthenolide, sesquiterpene lactones | Migraine prophylaxis | Moderate (reduces frequency) | 50-150 mg/day (parthenolide content 0.2-0.4%) |
| Black Cohosh (Actaea racemosa) | Root | Triterpene glycosides (actein, cimicifugoside) | Menopause symptoms (hot flashes, night sweats) | Moderate for menopause | 20-40 mg/day standardized extract |
| Chamomile (Matricaria chamomilla) | Flower | Apigenin, chamazulene, bisabolol | Anxiety, insomnia, digestive upset, dermatological | Limited-moderate | 2-3 g dried flower TID as tea |
| Goldenseal (Hydrastis canadensis) | Root | Berberine, hydrastine | Digestive upset, infections | Limited (berberine has antimicrobial activity) | 500-1000 mg TID |
Herb-Drug Interactions
Clinically Significant Interactions
| Herb | Drug(s) | Interaction | Mechanism | Clinical Significance |
|---|---|---|---|---|
| St. John’s Wort | Cyclosporine, tacrolimus, sirolimus | Decreased drug levels (transplant rejection risk) | CYP3A4 and P-gp induction | High - avoid combination |
| St. John’s Wort | Warfarin | Decreased INR (reduced anticoagulation) | CYP induction | High - avoid or closely monitor |
| St. John’s Wort | Oral contraceptives | Breakthrough bleeding, reduced efficacy | CYP3A4 induction | High - use alternative contraception |
| St. John’s Wort | SSRIs, SNRIs, MAOIs | Serotonin syndrome | Additive serotonergic effect | High - avoid combination |
| St. John’s Wort | Antiretrovirals (PIs, NNRTIs) | Decreased drug levels | CYP3A4 induction | High - avoid |
| Ginkgo | Warfarin, NSAIDs, antiplatelet | Increased bleeding risk | Platelet-activating factor inhibition | Moderate - monitor for bleeding |
| Ginkgo | Thiazide diuretics | Increased blood pressure | Unknown | Low-moderate |
| Ginkgo | Proton pump inhibitors | Decreased ginkgo efficacy? | pH-dependent absorption | Low |
| Ginseng | Warfarin | Decreased INR | CYP induction | Moderate - monitor INR |
| Ginseng | Insulin, oral hypoglycemics | Hypoglycemia | Increased insulin secretion/potentiation | Moderate - monitor glucose |
| Kava | Benzodiazepines, alcohol | Additive CNS depression | GABA potentiation | High - avoid |
| Kava | CYP substrates | Multiple potential interactions | CYP inhibition (various) | Moderate |
| Valerian | Benzodiazepines, barbiturates | Additive sedation | GABA potentiation | Moderate |
| Goldenseal (berberine) | Cyclosporine, tacrolimus | Increased drug levels | CYP3A4 inhibition | Moderate - monitor levels |
| Garlic | Warfarin | Increased INR, bleeding | Antiplatelet effect | Moderate - monitor |
| Echinacea | Immunosuppressants | Reduced immunosuppression | Immune stimulation | Theoretical - avoid |
Safety and Adverse Effects
Quality and Contamination Issues
| Issue | Prevalence | Sources | Prevention |
|---|---|---|---|
| Adulteration | 5-30% (varies by herb) | Pharmaceutical drugs added, cheaper substitutes | Purchase from reputable manufacturers (USP/NSF verified) |
| Heavy metals | 5-20% | Soil contamination, manufacturing | Third-party testing certificate of analysis |
| Pesticide residues | Variable | Conventional farming | Choose organic when possible |
| Microbial contamination | Variable | Poor processing | Proper drying, sterilization |
| Misidentification | Rare but serious (e.g., digitalis mistaken for comfrey) | Inadequate quality control | Use established brands |
Potential Adverse Effects
| Herb | Adverse Effects | Frequency |
|---|---|---|
| St. John’s Wort | Photosensitivity (high doses), GI upset, dry mouth | Common (mild), photosensitivity rare |
| Kava | Severe hepatotoxicity (genetic susceptibility) | Rare but potentially fatal |
| Valerian | Headache, dizziness, morning drowsiness | Common (mild) |
| Ginkgo | Headache, nausea, dizziness, allergic skin reactions | Common (mild) |
| Saw Palmetto | Mild GI upset, decreased libido (rare) | Uncommon |
| Echinacea | Allergic reactions (in atopic individuals), GI upset | Uncommon |
| Black Cohosh | GI upset, rare hepatotoxicity | Mild common, hepatotoxicity rare |
| Yohimbe | Hypertension, tachycardia, anxiety, panic attacks | Common and potentially serious |
| Comfrey | Hepatotoxicity, carcinogenicity (pyrrolizidine alkaloids) | Significant - avoid internal use |
| Ephedra | Hypertension, arrhythmia, stroke, death | Serious - FDA banned (US) |
Regulatory Status
| Region | Regulatory Framework | Quality Standards |
|---|---|---|
| United States | Dietary Supplement Health and Education Act (DSHEA) 1994 | Manufacturing (GMP), labeling standards, no pre-market approval for safety/efficacy |
| European Union | Traditional Herbal Medicinal Products Directive (THMPD) | Registration for traditional use, safety and quality standards |
| Canada | Natural Health Products Regulations | Product licensing, site licensing, good manufacturing practices |
| Australia | Therapeutic Goods Administration (TGA) | Listed or registered medicines, quality standards |
| China | State Food and Drug Administration (SFDA) | Dual system: food (supplements) and drug (TCM) classification |
| India | Ministry of AYUSH | Standards for Ayurvedic, Siddha, Unani products |
Conclusion
Herbal medicine offers valuable therapeutic options, particularly for chronic conditions, mild-to-moderate mood disorders, and symptom management. Many herbs have clinically meaningful efficacy supported by research. However, quality variability, potential herb-drug interactions, and self-treatment risks require careful consideration. Herbal products should be purchased from reputable manufacturers, used under professional guidance, and discussed with healthcare providers to ensure safe integration with conventional treatments.